Host: Randy Young, MD Guest: Daniel Jay Feinstein, MD, FACP, MS, ACRP-PI Diagnosing pneumonia can be challenging, but the CAP guidelines offer recommendations to improve the detection of this infection. To find out more about the recommendations, Dr. Randy Young and Dr. Daniel Feinstein, a Physician Executive at Novant Health, dive into testing for pneumonia. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.

Host: Randy Young, MD Guest: Tufik Assad, MD, MSCI What are the factors that make diagnosing pneumonia challenging, and how might emerging testing modalities improve that? To answer this question, Dr. Randy Young and Dr. Tufik Assad from the Williamson Medical Center in Franklin, Tennessee dive into the etiology, diagnostic challenges, and current trends in pneumonia diagnostics. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.

Host: David Schulman, MD, MPH, FCCP Guest: William Lago, MD Guest: Tejaswini Kulkarni, MD, MPH, FCCP What are some of the barriers to early diagnosis for idiopathic pulmonary fibrosis (IPF)? Joining Dr. David Schulman to share their perspectives on the latest diagnostic challenges and provide strategies to combat them are Drs. Tejaswini Kulkarni and William Lago. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation.

Host: Frank C. Sciurba, MD, FCCP Guest: Emily L. Yee, MD What do we need to know about using endobronchial valves in patients with severe COPD and emphysema? Drs. Frank Sciurba and Emily Yee explore the impact of these valves on patients. This educational podcast is produced in partnership with the American College of CHEST Physicians and sponsored by Pulmonx Corporation, the manufacturer of Zephyr. Click here to find additional educational resources for clinicians and patients.

Host: Ashwin Basavaraj, MD Nontuberculous mycobacteria (NTM) and bronchiectasis are challenging diseases that require a multidisciplinary approach to treat. Dr. Ashwin Basavaraj sits down with his patient, Mary, to learn more about these obstacles and discuss how we can find the right care team. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Doreen Addrizzo-Harris, MD Guest: Ashwin Basavaraj, MD From evaluating diagnostic criteria to nonpharmacologic therapy, what do the NTM guidelines recommend when it comes to the treatment of MAC lung disease? Drs. Doreen Addrizzo-Harris and Ashwin Basavaraj from NYU Grossman School of Medicine will dive into the practical application of the NTM guidelines. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Narjust Duma, MD Guest: Janani Reisenauer, MD Guest: Colleen Channick, MD, FCCP, DAABIP A multidisciplinary panel including a medical oncologist, a thoracic surgeon, and an interventional pulmonologist will discuss the role of lung cancer teams in their thoracic oncology practices. The panelists will review their management of patients with lung cancer during the COVID-19 pandemic, including the impact of delayed procedures and telemedicine on patient outcomes.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Narjust Duma, MD Guest: Andreas Rimner, MD Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers.

Host: Eric Edell, MD, FCCP Host: Septimiu Murgu, MD, FCCP Guest: Narjust Duma, MD Guest: Christopher Hartley, MD Guest: Jeffrey Mueller, DO Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid biopsy and comprehensive genetic and PD-L1 testing in the management of advanced lung cancer. The panelists will also explore various strategies for optimizing the quantity and quality of cytology and small volume biopsy specimens.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Nichole Tanner, MD, MS, FCCP Guest: Fabien Maldonado, MD, FCCP Two internationally known interventional pulmonologists will discuss current guidelines and their own experiences regarding sampling of lung lesions and mediastinal adenopathy. Specifically, the panelists will discuss the pros and cons of various diagnostic strategies and sampling techniques, including transcutaneous and bronchoscopic biopsies. This interactive webinar will offer the opportunity for learners to ask questions prior to and during the event. Learning is augmented by a few follow-up quizzes weeks after the webinar, a strategy proven to improve knowledge gain and retention.